370 related articles for article (PubMed ID: 34826977)
21. [Assessment of Langerhans Cells in the Central Cornea as Tool for Monitoring Inflammatory Changes in Patients with Keratoconjunctivitis sicca under Topical Therapy with Cyclosporine A 0.05% Eye Drops].
Schneider E; Paulsen F; Jacobi C
Klin Monbl Augenheilkd; 2020 May; 237(5):669-674. PubMed ID: 32434251
[TBL] [Abstract][Full Text] [Related]
22. Association of Ramadan daytime fasting with ocular surface inflammation and dry eye.
Armstrong BK; Coc IR; Agarwal P; Smith S; Navon S
Int Ophthalmol; 2019 Dec; 39(12):2857-2863. PubMed ID: 31152289
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial.
Akpek EK; Wirta DL; Downing JE; Tauber J; Sheppard JD; Ciolino JB; Meides AS; Krösser S
JAMA Ophthalmol; 2023 May; 141(5):459-466. PubMed ID: 37022717
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus ≥ 55 years.
Mateo-Orobia AJ; Del Prado Sanz E; Blasco-Martínez A; Pablo-Júlvez LE; Farrant S; Chiambaretta F
Cont Lens Anterior Eye; 2023 Aug; 46(4):101845. PubMed ID: 37117131
[TBL] [Abstract][Full Text] [Related]
25. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
Cömez AT; Tufan HA; Kocabıyık O; Gencer B
Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
[TBL] [Abstract][Full Text] [Related]
26. Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma.
Zaleska-Żmijewska A; Strzemecka E; Wawrzyniak ZM; Szaflik JP
J Ophthalmol; 2019; 2019():1240537. PubMed ID: 31073413
[TBL] [Abstract][Full Text] [Related]
27. Short-Term Effects of Ground-Level Ozone in Patients With Dry Eye Disease: A Prospective Clinical Study.
Kim Y; Paik HJ; Kim MK; Choi YH; Kim DH
Cornea; 2019 Dec; 38(12):1483-1488. PubMed ID: 31299662
[TBL] [Abstract][Full Text] [Related]
28. Topical Low Dose Preservative-Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial.
Kallab M; Szegedi S; Hommer N; Stegmann H; Kaya S; Werkmeister RM; Schmidl D; Schmetterer L; Garhöfer G
Adv Ther; 2020 Jan; 37(1):329-341. PubMed ID: 31741283
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC
J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481
[TBL] [Abstract][Full Text] [Related]
30. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial.
Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS
Ocul Surf; 2021 Apr; 20():62-69. PubMed ID: 33401019
[TBL] [Abstract][Full Text] [Related]
31. The Lubricating Effect of Eye Drops Containing Hyaluronic Acid and Mallow Extract in Patients with Dry Eye Disease-A Pilot Study.
Basile AA; Mandelli G; Cendali M; Hufnagel R
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241190
[No Abstract] [Full Text] [Related]
32. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
33. Autologous serum eye drops for dry eye.
Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
[TBL] [Abstract][Full Text] [Related]
34. Effect of a formulated eye drop with
Tan J; Jia T; Liao R; Stapleton F
Br J Ophthalmol; 2020 Oct; 104(10):1373-1377. PubMed ID: 31949092
[TBL] [Abstract][Full Text] [Related]
35. A Multicenter, Randomized, Double-Blind Evaluation of the Efficacy of TJO-087 Versus 0.05% Cyclosporine A in Moderate to Severe Dry Eye.
Eom Y; Yoon KC; Kim HK; Song JS; Hyon JY; Kim HM
J Ocul Pharmacol Ther; 2023; 39(1):27-35. PubMed ID: 36450107
[No Abstract] [Full Text] [Related]
36. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
Yin J; Kheirkhah A; Dohlman T; Saboo U; Dana R
Am J Ophthalmol; 2018 Jun; 190():17-23. PubMed ID: 29572107
[TBL] [Abstract][Full Text] [Related]
37. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.
Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG
Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956
[TBL] [Abstract][Full Text] [Related]
38. Symptomatic dry eye disease among university students.
Al-Zubi KM; Al-Kubaisy WA; Al-Azzeh YE; Batayneh BK; Alqaraleh HA; Abid LA; Al-Jadid Al-Majali GO; Alhajaj NT
Med Hypothesis Discov Innov Ophthalmol; 2023; 12(2):70-77. PubMed ID: 38357613
[TBL] [Abstract][Full Text] [Related]
39. Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium.
Ji YW; Kim HM; Ryu SY; Oh JW; Yeo A; Choi CY; Kim MJ; Song JS; Kim HS; Seo KY; Kim KP; Lee HK
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5035-5044. PubMed ID: 31800960
[TBL] [Abstract][Full Text] [Related]
40. A comparative assessment of dry eye disease among outdoor street sweepers and indoor office cleaners.
Echieh CI; Etim BA; Echieh CP; Oyeniyi T; Ajewole J
BMC Ophthalmol; 2021 Jun; 21(1):265. PubMed ID: 34174855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
